ArticleScientific reports2026
Postharvest delivery of Bacillus G36 metabolites formulated in AgNP modifies Salvia rosmarinus Spenn. bioactive profiles.
Article in Scientific reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
This study explores the biological synthesis of silver nanoparticles (AgNPs) using elicitors (ML) from the beneficial bacterium Bacillus G36 and evaluates their potential to enhance bioactive compound production in postharvest rosemary (Salvia rosmarinus Spenn.). To determine optimal synthesis conditions, different ratios of ML to AgNO3 1mM were mixed, for 24 h, evaluating a range of temperatures (28–37) and pH (5, 7, 9), with and without rosemary extracts, which were characterized by TEM, FTIR, XRD and Zpotential. Two NP were selected based on size and organic crown for biological assay on rosemary. The best conditions were a 1:1 (vv) mixture of ML and silver nitrate, pH 9, 37 °C, producing nanoparticles with an average size of 7.5 nm (S3). These small AgNPs have shown great biological activity. In contrast, adding rosemary extract (RE) to nucleation media, in order to increase reductive media potential, yielded larger particles (≈ 63.9 nm) and reduced their effectiveness. Biological assays showed that S3 AgNPs significantly increased total phenol and flavonol contents in rosemary when applied in postharvest, while ML alone did not, highlighting the better effect of elicitors when formulated in NP. Remarkably, only S3 AgNPs enhanced rosmarinic acid levels by 50%. Both S3 AgNPs and live Bacillus G36 cells also boosted diterpene (carnosic acid equivalents) concentrations. Despite effects on bioactives, only S3 and ML treatments increased the total antioxidant capacity of the extracts. Overall, the study demonstrates that biosynthesized S3 AgNPs from Bacillus G36 metabolites offer a sustainable and efficient approach to producing small, bioactive nanoparticles capable of improving and maintaining valuable phytochemicals in rosemary postharvest.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.